{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:59:21Z","timestamp":1770890361055,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bja.2022.09.006","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T19:21:36Z","timestamp":1664997696000},"page":"e171-e172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Delayed emergence after remimazolam induction in end-stage liver disease. Comment on Br J Anaesth 2021; 127: 415\u201323"],"prefix":"10.1016","volume":"129","author":[{"given":"Amit","family":"Singal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6960-7172","authenticated-orcid":false,"given":"Rotem","family":"Naftalovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad R.","family":"Syed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faraz A.","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"Discepola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel T.","family":"Rodriguez-Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2022.09.006_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bja.2021.05.027","article-title":"Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment","volume":"127","author":"St\u00f6hr","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2022.09.006_bib2","unstructured":"European Medicines Agency. Byfavo: EPAR - Product information 2022. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/byfavo-epar-product-information_en.pdf (accessed 19 August 2022)."},{"key":"10.1016\/j.bja.2022.09.006_bib3","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.23736\/S0375-9393.21.15517-8","article-title":"Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia","volume":"87","author":"Dai","year":"2021","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.bja.2022.09.006_bib4","first-page":"491","article-title":"Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial","volume":"34","author":"Doi","year":"2020","journal-title":"J\u00a0Anesth"},{"key":"10.1016\/j.bja.2022.09.006_bib5","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2147\/DDDT.S359496","article-title":"Quality of recovery after general anesthesia with remimazolam in patients undergoing urologic surgery: a randomized controlled trial comparing remimazolam with propofol","volume":"16","author":"Mao","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.bja.2022.09.006_bib6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12871-021-01530-3","article-title":"Remimazolam for induction of anesthesia in elderly patients with severe aortic stenosis: a prospective, observational pilot study","volume":"21","author":"Nakanishi","year":"2021","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.bja.2022.09.006_bib7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/bja\/81.6.881","article-title":"Metabolism of remifentanil during liver transplantation","volume":"81","author":"Navapurkar","year":"1998","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2022.09.006_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/00498254.2019.1678078","article-title":"Is genetic variability in carboxylesterase-1 and carboxylesterase-2 drug metabolism an important component of personalized medicine?","volume":"50","author":"Laizure","year":"2020","journal-title":"Xenobiotica"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000709122200513X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000709122200513X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:03:08Z","timestamp":1757790188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000709122200513X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S000709122200513X"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2022.09.006","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delayed emergence after remimazolam induction in end-stage liver disease. Comment on Br J Anaesth 2021; 127: 415\u201323","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2022.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2021.05.027","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd on behalf of British Journal of Anaesthesia.","name":"copyright","label":"Copyright"}]}}